It has been reported that PMEPA1 could exacerbate triple-negative breast cancer (TNBC) tumor progression by increasing PTEN turnover and attenuating PTEN expression to promote the expression of atypical PI3K/AKT signaling. Here, AKT1 is linked to triple-negative breast carcinoma.